Artificial Intelligence: A Transformative Journey for Pharmacovigilance
September 27, 2018

Pharmacovigilance, just like drug development, is an iterative process where all stakeholders work proactively and collaboratively to ensure a systematic approach to safety monitoring. The industry is transitioning to more active safety surveillance activities, creating greater demands for more comprehensive and innovative approaches. Today, AI and machine learning are being viewed as providing potential insights for enhancing patient safety. While still early in usage, AI is demonstrating the feasibility to predict potential issues, further enhancing patient safety in clinical trials.

Join this webinar to learn how AI is transforming clinical development and enhancing patient safety.

Contact Us
Contact Us

Email Us

Interested in learning more about how IQVIA can create solutions to help you drive healthcare forward?

Call Us

We're available during standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.

Media Inquiries

Please note that forms have been updated on SC9 PROD, it may be good to update the SC9 DEV forms with SC9 PROD.